Media Center

Filter by year:

Sep 25, 2025

Generate:Biomedicines to Present Phase 1 Results for AI-Engineered GB-0895 in Asthma at the European Respiratory Society International Congress

Sep 17, 2025

Generate:Biomedicines Welcomes Laurie Lee, MD, as Chief Medical Officer for the Immunology & Inflammation Portfolio

Apr 01, 2025

Generate:Biomedicines Expands Board of Directors with Appointment of Marsha Fanucci

Jan 09, 2025

Generate:Biomedicines Provides Update on its Platform and Pipeline Powered by AI at the 43rd Annual J.P. Morgan Healthcare Conference

Sep 24, 2024

Generate:Biomedicines Announces Multi-Target Collaboration with Novartis to Discover and Develop Protein Therapeutics with Generative AI

Jun 13, 2024

Generate:Biomedicines Expands Board of Directors with the Appointment of Rupert Vessey, M.D., Ph.D., and Nancy Simonian, M.D.

Apr 30, 2024

Generate:Biomedicines Expands C-suite with Chief Corporate Affairs Officer and Chief Technical Operations Officer

Jan 04, 2024

Generate:Biomedicines Fortifies Leadership in Generative AI with Advancing Clinical Pipeline and Expanded Amgen Collaboration, Overviewed at the 42nd Annual J.P. Morgan Healthcare Conference

Nov 15, 2023

Generate:Biomedicines Announces Publication of its Chroma Model in Nature: A Transformative Generative AI for Protein Therapeutics

'